Rymarz Zdort advises HigoSense on EUR 5 million Series A funding round

10 January 2022

Rymarz Zdort advised HigoSense sp. z o.o. (“HigoSense”), a Warsaw-based digital healthcare provider, and its founders in connection with a EUR 5 million Series A funding round led by Cogito Capital Partners, with the participation of existing early-stage investors.

HigoSense, is a health-tech start-up established in 2017 offering a mobile medical examination device that is supported by a mobile app and an online AI-powered health diagnostic platform. HigoSense enables doctors to perform high-quality remote patient examinations and patients to perform examinations, as well as collect diagnostic data prior to or during a telehealth session.

Cogito Capital Partners focuses on providing support in management, financing and market expansion to technology companies with high-growth potential and helping them expand internationally.

The team advising on the transaction comprised Paweł Zdort, a managing partner, supported by Monika Michałowska, an associate. Robert Krasnodębski, a partner, was responsible for the tax aspects of the transaction.

Team members

Paweł Zdort

Managing Partner

Paweł Zdort

Robert Krasnodębski

Partner

Robert Krasnodębski

Monika Michałowska

Associate

Monika Michałowska

More news